Industry leaders describe how proteomics is shifting toward clinical and applied use through standardized workflows, scalable ...

Cardiovascular diseases (CVDs) remain a leading cause of global morbidity and mortality, with significant residual risk unexplained by traditional factors. The discovery of novel therapeutic targets ...

Proteomics as a concept concerns the study of the complete set of proteins expressed by an organism since the molecules carry out nearly every bodily activity.

Researchers used advanced imaging to uncover early molecular changes in bone that may enable earlier diagnosis of ...

According to Mordor Intelligence, the proteomics market size was valued at USD 29.92 billion in 2025 and projected to grow from USD 33.47 billion in 2026 to reach USD 58.66 billion by 2031, at a CAGR ...

This proteomics-driven approach to drug discovery improves target validation and uncovers insights into undruggable proteins, ...

This overview explains how proteomics sample preparation underpins mass spectrometry performance. It details best practices ...

The proteomics market is experiencing strong growth as demand rises for advanced tools that analyze protein structure, ...

Proteomics is the large-scale study of proteins, particularly their structures and functions. It involves the systematic identification, quantification, and analysis of the entire protein complement ...

The global proteomics market was valued at $29.9 billion in 2025 and is forecast to grow to $58.7 billion by 2031, according ...

For individuals with MS, proteomic analysis offers insight into the role disease progression plays in affecting both biological and chronological age progression as well as mortality risk, according ...

Japan Nine Months Ended December 31 PARENT 2025 2024 Revenue Y103.00 mln Y83.00 mln Operating Profit (Y573.00 mln) (Y630.00 mln) Pretax Profit (Y509.00 mln) (Y624.00 mln) Net Profit (Y547.00 mln) ...